Toward more efficient clinical trials for amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Toward more efficient clinical trials for amyotrophic lateral sclerosis

Published:2009-12-04 Issue:3 Volume:11 Page:259-265
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Cudkowicz Merit E.,Katz Jon,Moore Dan H.,O’neill Gilmore,Glass Jonathan D.,Mitsumoto Hiroshi,Appel Stanley,Ravina Bernard,Kieburtz Karl,Shoulson Ira,Kaufmann Petra,Khan Jaffar,Simpson Ericka,Shefner Jeremy,Levin Bruce,Cwik Valerie,Schoenfeld David,Aggarwal Swati,McDermott Michael P.,Miller Robert G.

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/17482960903358865

Reference22 articles.

1. Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment

2. Polishing, sensing, switching and synthesizing.

3. PTC124 targets genetic disorders caused by nonsense mutations

4. Impact of amyloid imaging on drug development in Alzheimer's disease

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological Quality of Clinical Trials in Amyotrophic Lateral Sclerosis: A Systematic Review;Journal of Neuromuscular Diseases;2024-07-02

2. At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis;Nature Communications;2023-08-21

3. Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis;2023-03-30

4. A machine-learning based objective measure for ALS disease severity;npj Digital Medicine;2022-04-08

5. Unintended Consequences of Approving Unproven Treatments—Hope, Hype, or Harm?;JAMA Neurology;2022-02-01